Western blotting revealed that HCC exosomes inhibited the expression of CYLD and activated the NF-κB pathway in neutrophils, and these effects were reversed by treatment with the miR-362-5p inhibitor (Figure 6M). Here, CYLD is linked to hepatocellular carcinoma.